The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Meade Harry since 2007.
The trader's CIK number is 1241322.
At the time of the last reporting, Meade Harry was the SVP, Transgenic Rese of Gtc Biotherapeutics Inc. (stock ticker symbol GTCB).
Also see all insider trading activities at Gtc Biotherapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | GTCB | 10,000 | $9,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-12-14 | GTCB | Buy | 10,000 | .90 | 9,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meade Harry (SVP, Transgenic Rese of Gtc Biotherapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.